BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

HeartSciences Announces Further Internationalization of its Patent Portfolio

Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical te...

February 06, 2023 | News

SK bioscience Receives Upgrade MSCI ESG Rating

According to the rating report, SK bioscience was recognized for its human resources development in the social(S) category and transparency of the board of...

February 03, 2023 | News

Lunit's AI solution is the first application tool that enhance Guardant Health's portfolio of cancer tests

Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC Lunit...

February 02, 2023 | News

SK bioscience’s World First Cell Culture-Based Influenza Vaccine Is Approved in Chile

The world first cell culture-based influenza vaccine, ‘SKYCellflu™’ is approved for the first time in South America SKYCellflu&t...

February 02, 2023 | News

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

SK bioscience shared a development history of the South Korea’s first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBM...

January 27, 2023 | News

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...

January 26, 2023 | News

GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy

This collaboration will utilize GenKOre's proprietary CRISPR-Cas platform, TaRGET (Tiny nuclease, augment RNA-...

January 26, 2023 | News

Genexine Receives Fast Track Designation from Korean Health Authority (MFDS) for its promising DNA vaccine for advanced cervical cancer

Following an evaluation of the full set of Phase 2 data from the recently completed clinical trial in advanced cervical cancer, Korea’s Health Author...

January 23, 2023 | News

South Korean diagnostics company NGeneBio is accelerating its expansion into the ASEAN precision diagnosis market.

▶ Securing breast and ovarian cancer precision diagnosis reference through clinical evaluation ▶ Expansion of opportunities to develops global advance...

January 19, 2023 | News

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

"We are pleased to collaborate with SK bioscience to offer our protein-based vaccine, Nuvaxovid, for use as a booster in adults regardless of previous vacc...

January 19, 2023 | News

Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes

Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping Lunit's presentations this year will highligh...

January 19, 2023 | News

Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative's ...

January 11, 2023 | News

LegoChem Biosciences and Amgen Enter into a Multi-Target Research Collaboration

LCB Grants Amgen Rights to Research, Develop, and Commercialize Antibody-Drug Conjugates Combining Targets Selected by Amgen with LCB’s Proprieta...

December 26, 2022 | News

SK Biopharmaceuticals Unveils Vision for Digital Healthcare

SK Biopharmaceuticals plans to showcase wearable devices, including CES® 2023 Innovation Awards winners 'Zero GlassesTM,' 'Zero WiredTM'...

December 14, 2022 | News

Stay Connected